>
Innovating Value Chains

dehaze

dehaze is building a foundational AI model for chronic disease detection, enabling health insurers to identify at-risk patients years before costly clinical events occur. By processing the full breadth of fragmented patient data, the platform closes a critical gap in healthcare where over 30% of chronic diseases go undetected due to limited data usage in clinical decision-making. With demonstrated potential to reduce healthcare spending by up to 10%, dehaze is positioning itself as a category-defining infrastructure layer for proactive, data-driven population health management

Details

Headquarters

Germany

Current Stage

Seed

Backed by YZR

Co-Investors

DN Capital, Angel Invest, Better Ventures, ZOHO VC

News

Updates
May 4, 2026

dehaze raises €3.2M for AI chronic disease detection

Read Article